.jpg "FDA Grants Fast Track Designation for Heart Failure Developmental Treatment")
.jpg "Masitinib Reduced Exacerbation Rate in Patients with Severe Persistent Asthma")
.jpg "Patient Characteristics May Not Always Determine Effectiveness of Biologics for Asthma")
A phase 3 clinical trial for apremilast showed “significant improvements” in patients with mild-to-moderate plaque psoriasis, according to a press release from the manufacturer...
.jpg "Positive Results Reported from Phase 3 Plaque Psoriasis Trial")
.jpg "First-Line Andecaliximab with mFOLFOX6 Fails to Improve Advanced Gastric Cancer Survival")
By Gene Emery (Reuters Health) - Six doses of rituximab can help children with high-grade, high-risk mature B-cell non-Hodgkin's lymphoma live longer, but at a risk of infections and Read More »
By Marilynn Larkin NEW YORK (Reuters Health) - Evidence is lacking on the effectiveness of noninvasive ventilation (NIV) and invasive mechanical ventilation (IMV) for COVID-19 patients, and the safety Read More »
By Lisa Rappaport (Reuters Health) - Women who experience migraines during pregnancy are more likely to have a stroke during pregnancy, delivery, or the postpartum period, a new study suggests. Read More »
By Lisa Rappaport (Reuters Health) - IntelliCare, a coach-supported suite of apps designed to improve mental health, may help ease depression and anxiety symptoms in primary care patients, a small Read More »
By Nancy Lapid June 3 (Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the Read More »
By Gene Emery (Reuters Health) - The risk of suicide by firearm jumps 100-fold during the first month after purchasing a handgun, even if the buyer is subject to a 10-day waiting period, according to Read More »
By Michael Erman (Reuters) - The malaria drug promoted by U.S. President Donald Trump as a treatment for COVID-19 was shown to be ineffective in preventing infection in people exposed to the Read More »
By Linda Carroll (Reuters Health) - High cholesterol is on the rise in low- and middle-income countries while declining in wealthier ones, an international team of researchers finds in a new analysis. Read More »
